臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin c c"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1291-1300 of 2549 (255 Page(s) Totally)
<< < 125 126 127 128 129 130 131 132 133 134 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-05-26T09:27:19Z	Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer	Lin C.-C;Chih-Hsin Yang; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:18Z	Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors	Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T.
臺大學術典藏	2020-05-26T09:27:17Z	Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.	Shao Y.Y;Lin C.C;Chih-Hsin Yang; Shao Y.Y; Lin C.C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:14Z	Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations	Lin C.-C;Chih-Hsin Yang; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:10Z	Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC	Medema R.H;Lin C.-C;Chih-Hsin Yang; Medema R.H; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:03Z	First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developments	Liao B.-C;Lin C.-C;Chih-Hsin Yang; Liao B.-C; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:02Z	EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer	Kao H.-F;Lin C.-C;Chih-Hsin Yang; Kao H.-F; Lin C.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer	Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:27:00Z	A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors	Ghamande S; Lin C.-C; Cho D.C; Shapiro G.I; Kwak E.L; Goel S.; Chuadhary I; Ghalib M.H; Cheng A.-L; CHIH-HSIN YANG; Coleman T; Silverman M.H; Tseng Y; Kuo M.-W; Mach W.B; Hsu S.-C
臺大學術典藏	2020-05-26T09:26:59Z	First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial	CHIH-HSIN YANG; Kang J.H; Mok T; Ahn M.-J; Srimuninnimit V; Lin C.-C; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.

Showing items 1291-1300 of 2549 (255 Page(s) Totally)
<< < 125 126 127 128 129 130 131 132 133 134 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52922708 Online Users : 743 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library